Europe Fast Tracks Process for BioNTech/Pfizer COVID-19 Drug

GALWAY, IRELAND--October 19, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The European Union (EU) has begun a "rolling review" of the COVID-19 vaccine being developed by Germany's BioNTech (NASDAQ: BNTX) and U.S. major Pfizer (NYSE:PFE) with a view to fast-tracking its rollout.

Within this article: Details rolling review of COVID-19 drug candidates, potential to fast-track rollout, deals related to production capacity in Europe